Scholarlink

Background <p>Wireless telemetry from fully implanted, millimeter-scale neuromodulation devices is constrained by tight power budgets, inefficient antennas, and in-body attenuation. Standard protocols (e.g., BLE) offer mature ecosystems but exhibit throughput shortfalls and reduced robustness under non-ideal operating conditions. This study introduces the Neural Real-Time Telemetry Protocol (NRTP), a 2.4&#xa0;GHz, half-duplex protocol designed to address the unmet need for reliable, real-time neural telemetry from miniaturized implants using off-the-shelf hardware, without custom electronics or ASICs.</p> Methods <p>NRTP was implemented on commercial 2.4&#xa0;GHz hardware with static-length packets, immediate acknowledgments, bounded retransmissions, and single RF channel operation. We evaluated three mitigation strategies—retries, sample-level interleaving, and data overlapping—individually and in combination, and defined a quantitative evaluation metric that prioritizes data quality and power draw. Using identical hardware for NRTP and BLE, we performed controlled sweeps of received signal strength, tested multiple payload lengths and timing configurations, and measured throughput, data loss, and current draw.</p> Results <p>NRTP sustained zero data loss down to -75 dBm, whereas BLE performance degraded below -55 dBm due to throughput shortfalls under interference and deferred unlimited retries. Interleaving converted contiguous gaps into half-rate segments, delaying score decline at lower received signal strength; overlapping improved robustness but its doubled packet rate requirement was power-prohibitive for implant constraints. Across variants, NRTP delivered higher scores and lower variability over a wider operational range than BLE; BLE’s greater scores at high signal strength were driven by lower current consumption but fell off earlier with attenuation. The observed link-margin advantage for NRTP (up to ~ 23&#xa0;dB at first loss; ~ 11&#xa0;dB at 0.5% loss) implies ~ 3.2 × range in air, ~ 2.5&#xa0;cm greater implant depth in tissue, or equivalently lower TX power for similar performance.</p> Conclusions <p>NRTP provides robust telemetry for miniaturized implantable devices and is readily adoptable on commodity 2.4&#xa0;GHz hardware. Its immediate, bounded retries and optional interleaving sustain throughput and minimize true data gaps under attenuation and interference, outperforming BLE across operating conditions relevant to small-animal implants. The resulting link-margin gains translate into practical benefits in coverage, implant depth, and power consumption, lowering barriers to chronic, closed-loop studies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A robust, real‑time telemetry protocol for miniaturized neural implants using off‑the‑shelf hardware

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月7日

查看全文
  • Mohamed Elgohary,
  • Michael Recine,
  • Jason Wong,
  • Timir Datta-Chaudhuri

摘要

Background

Wireless telemetry from fully implanted, millimeter-scale neuromodulation devices is constrained by tight power budgets, inefficient antennas, and in-body attenuation. Standard protocols (e.g., BLE) offer mature ecosystems but exhibit throughput shortfalls and reduced robustness under non-ideal operating conditions. This study introduces the Neural Real-Time Telemetry Protocol (NRTP), a 2.4 GHz, half-duplex protocol designed to address the unmet need for reliable, real-time neural telemetry from miniaturized implants using off-the-shelf hardware, without custom electronics or ASICs.

Methods

NRTP was implemented on commercial 2.4 GHz hardware with static-length packets, immediate acknowledgments, bounded retransmissions, and single RF channel operation. We evaluated three mitigation strategies—retries, sample-level interleaving, and data overlapping—individually and in combination, and defined a quantitative evaluation metric that prioritizes data quality and power draw. Using identical hardware for NRTP and BLE, we performed controlled sweeps of received signal strength, tested multiple payload lengths and timing configurations, and measured throughput, data loss, and current draw.

Results

NRTP sustained zero data loss down to -75 dBm, whereas BLE performance degraded below -55 dBm due to throughput shortfalls under interference and deferred unlimited retries. Interleaving converted contiguous gaps into half-rate segments, delaying score decline at lower received signal strength; overlapping improved robustness but its doubled packet rate requirement was power-prohibitive for implant constraints. Across variants, NRTP delivered higher scores and lower variability over a wider operational range than BLE; BLE’s greater scores at high signal strength were driven by lower current consumption but fell off earlier with attenuation. The observed link-margin advantage for NRTP (up to ~ 23 dB at first loss; ~ 11 dB at 0.5% loss) implies ~ 3.2 × range in air, ~ 2.5 cm greater implant depth in tissue, or equivalently lower TX power for similar performance.

Conclusions

NRTP provides robust telemetry for miniaturized implantable devices and is readily adoptable on commodity 2.4 GHz hardware. Its immediate, bounded retries and optional interleaving sustain throughput and minimize true data gaps under attenuation and interference, outperforming BLE across operating conditions relevant to small-animal implants. The resulting link-margin gains translate into practical benefits in coverage, implant depth, and power consumption, lowering barriers to chronic, closed-loop studies.